HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Deuson, R R Articles by Judson, F N Search for Related Content PubMed PubMed Citation Articles by Deuson, R R Articles by Judson, F N

The Denver school-based adolescent hepatitis B vaccination program: a cost analysis with risk simulation.

R R Deuson, E J Hoekstra, R Sedjo, G Bakker, P Melinkovich, D Daeke, A L Hammer, D Goldsman and F N Judson

National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Ga. 30333, USA. rgd3@cdc.gov

OBJECTIVES: This study sought to compare the cost-effectiveness of a school-based hepatitis B vaccine delivery program with that of a vaccine delivery program associated with a network health maintenance organization (HMO). METHODS: The vaccination program enrolled 3359 sixth-grade students from 18 middle schools in Denver, Colo. Immunization status and direct and indirect program costs were compiled. The sensitivity of the outcomes was assessed by simulation methods. RESULTS: The per-dose cost-effectiveness ratio for the school-based delivery system was $31. This cost-effectiveness ratio remained stable when the model was simulated with costs that were underestimated or overestimated by 20%. In the network HMO, the direct cost per dose was $68 and the societal cost was $118 when the child's father worked full-time and the mother worked part-time. There is less than a 5% chance that the network HMO-based vaccination program could be more cost-effective than the school-based program. CONCLUSIONS: The cost per dose of the school-based program was significantly less than that of the network HMO-based program, because in the school program government-purchased vaccine was available at a lower cost and parents did not incur work-loss costs.

This article has been cited by other articles:

				M. C. Lindley, L. Boyer-Chu, D. B. Fishbein, M. Kolasa, A. B. Middleman, T. Wilson, J. Wolicki, S. Wooley, and for the Working Group on the Role of Schools in De The Role of Schools in Strengthening Delivery of New Adolescent Vaccinations Pediatrics, January 1, 2008; 121(Supplement_1): S46 - S54. [Abstract] [Full Text] [PDF]

				F. Averhoff, L. Linton, K. M. Peddecord, C. Edwards, W. Wang, and D. Fishbein A Middle School Immunization Law Rapidly and Substantially Increases Immunization Coverage Among Adolescents Am J Public Health, June 1, 2004; 94(6): 978 - 984. [Abstract] [Full Text] [PDF]

				J. E. Glazner, B. L. Beaty, K. A. Pearson, and S. Berman The Cost of Giving Childhood Vaccinations: Differences Among Provider Types Pediatrics, June 1, 2004; 113(6): 1582 - 1587. [Abstract] [Full Text] [PDF]

				F. Zhou, G. L. Euler, S. J. McPhee, T. Nguyen, T. Lam, C. Wong, and J. Mock Economic Analysis of Promotion of Hepatitis B Vaccinations Among Vietnamese-American Children and Adolescents in Houston and Dallas Pediatrics, June 1, 2003; 111(6): 1289 - 1296. [Abstract] [Full Text] [PDF]

				F. Zhou, K. M. Bisgard, H. R. Yusuf, R. R. Deuson, S. K. Bath, and T. V. Murphy Impact of Universal Haemophilus influenzae Type b Vaccination Starting at 2 Months of Age in the United States: An Economic Analysis Pediatrics, October 1, 2002; 110(4): 653 - 661. [Abstract] [Full Text] [PDF]